Clinical Trial: A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090486) titled 'A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.' on July 21.

Brief Summary: This is a cohort study that will include Paxlovid (nirmatrelvir-ritonavir) treatment eligible for people with a positive SARS-CoV-2 diagnostic test and at least one COVID-19 symptom. This study will look at the change in Post Covid Conditions measured by the number of outpatients, Emergency department, urgent care and inpatient visits before and after COVID-19 between those who did and did not receive Paxlovid. In addition, changes in frailty post-acute infection will be evaluated, in a separate a...